''
Clinical

Clinical Trial Diversity & Intersectionality: Looking at the Whole Patient

Citeline joins an expert panel including a top 10 industry sponsor, a research and policy center, and an independent nonprofit organization to share actionable insights on expanding the scope of diversity in clinical trials.

ACRP 2025 event banner

About this event

ACRP 2025 is the leading clinical research conference that delivers gold-standard education and insights to boost your professional development—while ensuring quality and integrity in the clinical research process.

Join us for an insightful session as Citeline partners with an expert panel, which includes a top 10 industry sponsor, a research and policy center, and an independent nonprofit organization to share actionable insights on expanding the scope of diversity in clinical trials.


Don't miss our session

APR 26, 2025
3:15pm CT

Clinical Trial Diversity & Intersectionality: Looking at the Whole Patient

In this session, an expert panel with members representing a top 10 industry sponsor; a research and policy center; an independent nonprofit organization; and a pharmaceutical business intelligence provider will share actionable insights on expanding the scope of diversity in clinical trials. The panelists will elaborate on the section of the new U.S. Food and Drug Administration (FDA) diversity plan guidance stating that "FDA advises sponsors to seek diversity in clinical trial enrollment beyond populations defined by race and ethnicity, including other underrepresented populations defined by demographics.”

CEU: 1.00 ACRP

SPEAKERS
  • Headshot of Fenwick Eckhardt
    Fenwick Eckhardt Head of Diversity Strategy, Citeline
  • Headshot image of Meghan McKenzie
    Meghan McKenzie, MA Director of Health Equity and Clinical Research, Genentech's Chief Diversity Office
  • Headshot image of Behtash Bahador
    Behtash Bahador Director of Health Literacy, Center For Info & Study on Clinical Research Participation (CISCRP)
  • Headshot of Sylvia Baedorf Kassis.
    Sylvia Baedorf Kassis, MPH Program Director, Multi-Regional Clinical Trials Center of Brigham and Women's Hospital and Harvard